Some GLP-1 medications, like tirzepatide, also act on GIP (glucose-dependent insulinotropic polypeptide) receptors, which is why tirzepatide is sometimes called a "dual agonist." Mechanism of action (based on published research): According to research published in peer-reviewed journals, GLP-1 receptor agonists work through several mechanisms: They slow gastric emptying, which can increase feelings of fullness after meals
The full-service restaurant space hasnt really been impacted by GLP-1s, said CEO Rick Cardenas at the ICR Conference on Monday
This includes individuals with medical conditions such as pernicious anemia, atrophic gastritis, celiac disease, or Crohns disease, all of which can interfere with B12 absorption
JCI insight 5 , e140532 (2020)
In the first step, genetic variants associated with insomnia were used as instruments to assess the causal effect of insomnia on RTI
This means Mounjaro may offer greater weight loss results for some individuals